Make your money go further for just 25p per day

PREMIUM

Mega-Trends Portfolio: CRISPR is the future

17/03/2021

Trends US

CRISPR image

We have covered CRISPR/Cas9 before and hailed it as one of the most important inventions of the century. Several significant recent developments suggest that this revolutionary new technology is about to start realising its potential, which could clearly be significant for investors and constituents of our high-performing Mega Trends portfolio which rose 76% in 2020. Find out more in our update here.


CRISPR/Cas9 enables the editing of DNA; that’s all. It means we can edit the fundamental building blocks of nature that make us who we are. It also has the potential to wipe out certain diseases, radically improve crop yields, but a certain Vladimir Vladimirovich Putin once argued that genetic engineering “may be more terrifying than a nuclear bomb.”

If the concept of gene editing scares…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on bluebird bio

Mega-Trends Portfolio: CRISPR is the future

17/03/2021 · Portfolio

We have covered CRISPR/Cas9 before and hailed it as one of the most important inventions of…


More on CRISPR Therapeutics

Mega-Trends: next big thing is a step closer

27/11/2023 · Portfolio

A technology which could have an even bigger impact upon the world than AI has just…


An immense opportunity

30/08/2022 · Portfolio

CRISPR Therapeutics’ therapy for sickle cell disease could be available next year; this is incredibly exciting…


More on Editas Medicine

Mega-Trends Portfolio: CRISPR is the future

17/03/2021 · Portfolio

We have covered CRISPR/Cas9 before and hailed it as one of the most important inventions of…


More on GSK

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Company Insights

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…


Mega-Trends Portfolio: CRISPR is the future

17/03/2021 · Portfolio

We have covered CRISPR/Cas9 before and hailed it as one of the most important inventions of…


More on Intellia Therapeutics

Mega-Trends Portfolio: CRISPR is the future

17/03/2021 · Portfolio

We have covered CRISPR/Cas9 before and hailed it as one of the most important inventions of…


More on Novartis

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Company Insights

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…


Mega-Trends: A troubling 2021 opens opportunities for recovery

11/02/2022 · Portfolio

Sign-up to our free email updates

SIGN UP